Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer

Oncogene

Volumn 31, Issue 12, 2012, Pages 1599-1608

  Caldwell, M E ^a   Denicola, G M ^a   Martins, C P ^a   Jacobetz, M A ^a   Maitra, A ^b   Hruban, R H ^b   Tuveson, D A ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ADM; Kras; PanIN; PDA; SA gal; senescence

Indexed keywords

BETA GALACTOSIDASE; PROTEIN P21; PROTEIN P53; TUMOR MARKER;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM; HUMAN; HUMAN CELL; METAPLASIA; MOUSE; NONHUMAN; ONCOGENE; PANCREAS CANCER; PANCREAS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENESCENCE; STEM CELL; TUMOR MICROENVIRONMENT;

ANIMALS; BETA-GALACTOSIDASE; CARCINOMA, PANCREATIC DUCTAL; CELL AGING; DISEASE PROGRESSION; HUMANS; METAPLASIA; MICE; MUTATION; PANCREATIC NEOPLASMS; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL;

MURINAE;

EID: 84860389717     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.350     Document Type: Article

References (43)

1. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S et al. (2008). Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133: 1006-1018. (Pubitemid 351795610)
2. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N et al. (2006). Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637. (Pubitemid 44864442)
3. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B et al. (2005). Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660-665. (Pubitemid 41117262)
4. Campisi J, d'Adda di Fagagna F. (2007). Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740. (Pubitemid 47312822)
5. Chien Y, Lowe SW. (2008). Secreting tumor suppression. Cell 132: 339-341. (Pubitemid 351192003)
6. Collado M, Blasco MA, Serrano M. (2007). Cellular senescence in cancer and aging. Cell 130: 223-233. (Pubitemid 47081143)
7. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M et al. (2005). Tumour biology: senescence in premalignant tumours. Nature 436: 642. (Pubitemid 41117258)
8. Collado M, Serrano M. (2006). The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 6: 472-476.
9. Courtois-Cox S, Genther Williams SM, Reczek EE, Johnson BW, McGillicuddy LT, Johannessen CM et al. (2006). A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 10: 459-472. (Pubitemid 44872980)
10. Courtois-Cox S, Jones SL, Cichowski K. (2008). Many roads lead to oncogene-induced senescence. Oncogene 27: 2801-2809. (Pubitemid 351620451)
11. D'Adda di Fagagna F. (2008). Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 8, 512-522. (Pubitemid 351881854)
12. Dankort D, Filenova E, Collado M, Serrano M, Jones K, McMahon M. (2007). A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev 21: 379-384.
13. De La OJ, Emerson LL, Goodman JL, Froebe SC, Illum BE, Curtis AB et al. (2008). Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci USA 105: 18907-18912.
14. Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, Delmas V et al. (2009). Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell 15: 294-303.
15. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C et al. (2006). Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638-642. (Pubitemid 44864443)
16. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367.
17. Guerra C, Collado M, Navas C, Schuhmacher AJ, Hernandez-Porras I, Canamero M et al. (2011). Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 19: 728-739.
18. Habbe N, Shi G, Meguid RA, Fendrich V, Esni F, Chen H et al. (2008). Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci USA 105: 18913-18918.
19. Halazonetis TD, Gorgoulis VG, Bartek J. (2008). An oncogeneinduced DNA damage model for cancer development. Science 319: 1352-1355. (Pubitemid 351354863)
20. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA et al. (2003). Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4: 437-450. (Pubitemid 38050041)
21. Hruban RH, Adsay NV, Albores-Saavedra J, Anver MR, Biankin AV, Boivin GP et al. (2006). Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res 66: 95-106. (Pubitemid 43166014)
22. Hruban RH, Goggins M, Parsons J, Kern SE. (2000). Progression model for pancreatic cancer. Clin Cancer Res 6: 2969-2972. (Pubitemid 30637716)
23. Hruban RH, van Mansfeld AD, Offerhaus GJ, van Weering DH, Allison DC, Goodman SN et al. (1993). K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 143: 545-554. (Pubitemid 24058210)
24. Ivanova A, Liao SY, Lerman MI, Ivanov S, Stanbridge EJ. (2005). STRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation marker. J Med Genet 42: 565-576. (Pubitemid 40993832)
25. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C et al. (2008). Senescence of activated stellate cells limits liver fibrosis. Cell 134: 657-667.
26. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. (2010). The essence of senescence. Genes Dev 24: 2463-2479.
27. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ et al. (2008). Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133: 1019-1031. (Pubitemid 351787746)
28. Kuilman T, Peeper DS. (2009). Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 9: 81-94.
29. Lee KE, Bar-Sagi D. (2010). Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells. Cancer Cell 18: 448-458.
30. Majumder PK, Grisanzio C, O'Connell F, Barry M, Brito JM, Xu Q et al. (2008). A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression. Cancer Cell 14: 146-155.
31. Mallette FA, Gaumont-Leclerc MF, Ferbeyre G. (2007). The DNA damage signaling pathway is a critical mediator of oncogeneinduced senescence. Genes Dev 21: 43-48. (Pubitemid 46089705)
32. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM et al. (2005). BRAFE600-associated senescencelike cell cycle arrest of human naevi. Nature 436: 720-724. (Pubitemid 41117276)
33. Morton JP, Jamieson NB, Karim SA, Athineos D, Ridgway RA, Nixon C et al. (2010). LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest. Gastroenterology 139: 586-597, 597 e1-6.
34. Morton JP, Timpson P, Karim SA, Ridgway RA, Athineos D, Doyle B et al. (2009). Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci USA 107: 246-251.
35. Moskaluk CA, Hruban RH, Kern SE. (1997). p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 57: 2140-2143. (Pubitemid 27247028)
36. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA et al. (2003). Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703-716. (Pubitemid 36724935)
37. Prieur A, Peeper DS. (2008). Cellular senescence in vivo: a barrier to tumorigenesis. Curr Opin Cell Biol 20: 150-155.
38. Shi C, Hong SM, Lim P, Kamiyama H, Khan M, Anders RA et al. (2009). KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin. Mol Cancer Res 7: 230-236.
39. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM et al. (2001). Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1: 4.
40. Sun P, Yoshizuka N, New L, Moser BA, Li Y, Liao R et al. (2007). PRAK is essential for ras-induced senescence and tumor suppression. Cell 128: 295-308. (Pubitemid 46123511)
41. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. (2008). Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132: 363-374. (Pubitemid 351191995)
42. Young AR, Narita M, Ferreira M, Kirschner K, Sadaie M, Darot JF et al. (2009). Autophagy mediates the mitotic senescence transition. Genes Dev 23: 798-803.
43. Zhu L, Shi G, Schmidt CM, Hruban RH, Konieczny SF. (2007). Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am J Pathol 171: 263-273. (Pubitemid 47339243)